Effect of photobiomodulation on alleviating primary dysmenorrhea caused by PGF 2α .
Qiqi FuJiali YangHui JiangShangfei LinHaokuan QinJie ZhaoYanqing WangMuqing LiuPublished in: Journal of biophotonics (2024)
Photobiomodulation (PBM) has attracted widespread attention in suppressing various pain and inflammation. Primary dysmenorrhea (PD) primarily occurs in adolescents and adult females, and the limited effectiveness and side effects of conventional treatments have highlighted the urgent need to develop and identify new adjunct therapeutic strategies. In this work, the results of pain and PGs demonstrated that 850 nm, 630 nm, and 460 nm all exhibited pain inhibition, decreased PGF 2α and upregulated PGE 2 , while 630 nm PBM has better effectiveness. Then to explore the underlying biological mechanisms of red light PBM on PD, we irradiated prostaglandin-F 2α induced HUSM cells and found that low-level irradiance can restore intracellular calcium ion, ROS, ATP, and MMP levels to normal levels. And, red light enhanced cell viability and promoted cell proliferation for normal HUSM cells. Therefore, this study proposes that red light PBM may be a promising approach for the future clinical treatment of PD.
Keyphrases
- chronic pain
- induced apoptosis
- photodynamic therapy
- pain management
- randomized controlled trial
- cell proliferation
- cell cycle arrest
- neuropathic pain
- systematic review
- oxidative stress
- cell death
- young adults
- physical activity
- high glucose
- reactive oxygen species
- endoplasmic reticulum stress
- pi k akt
- working memory
- spinal cord
- wound healing
- light emitting
- endothelial cells
- drug induced
- smoking cessation